Nesiritide in a pediatric oncology patient with renal insufficiency and myocardial dysfunction following septic shock

Pediatric Hematology and Oncology

Volumn 22, Issue 4, 2005, Pages 323-333

  Wheeler, Adam D ^a   Tobias, Joseph D ^a,b,c  

^a University of Missouri   (United States)

^b University of Missouri ^*  (United States)

^c Pediatric Critical Care/Pediatric Anesthesiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BRAIN NATRIURETIC PEPTIDE; CHLOROTHIAZIDE; CREATININE; CYTARABINE; DAUNORUBICIN; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; DOXORUBICIN; ENALAPRIL; ETOPOSIDE; FUROSEMIDE; LIOTHYRONINE; METHOTREXATE; NESIRITIDE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BACTEREMIA; CASE REPORT; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DIURESIS; FLUID INTAKE; HEART AFTERLOAD; HEART FUNCTION; HEART OUTPUT; HEMODYNAMICS; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; KIDNEY FUNCTION; NATRIURESIS; NEUTROPENIA; OLIGURIA; RESPIRATORY FAILURE; SEPTIC SHOCK; SMOOTH MUSCLE RELAXATION; TACHYCARDIA; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; CARDIOMYOPATHIES; HUMANS; KIDNEY FAILURE; LEUKEMIA, MYELOCYTIC, ACUTE; NATRIURETIC PEPTIDE, BRAIN; RESPIRATORY INSUFFICIENCY; SHOCK, SEPTIC; TREATMENT OUTCOME; WATER-ELECTROLYTE BALANCE;

EID: 20044380742     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010590935248     Document Type: Article

References (23)

1. Morghal NE, Brocklebank JT, Meadow SR. A review of acute renal failure in children: incidence, etiology, and outcome. Clin Nephrol. 1998;49:91-95.
2. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units-causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter study. French Study Group on acute renal failure. Crit Care Med. 1996;24:192-198.
3. Mills RM, Hobbs RE. How to use nesiritide in treating decompensated heart failure. Clev Clin J Med. 2002;69:252-256.
4. Publication committee for VMAC investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:1531-1540.
5. Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovosc Dis. 2002;44:293-321.
6. Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol. 1992;54:11-27.
7. Abassi Z, Karram T, Ellaham S, et al. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther. 2004;102:223-241.
8. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure: the PROMISE study research group. New Engl J Med. 1991;325:1468-1475.
9. Silver MA, Horton DP, et al. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol. 2002;39:798-803.
10. Burger AJ, Horton DP, Lejemtel T, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J. 2002;144:1102-1108.
11. Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic, neurohormonal, and renal effect of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail. 1998;4:37-44.
12. Abraham WT, Adams KF, Fonarow GC, et al. Comparison of in-hospital mortality in patients treated with nesiritide vs. other parenteral vasoactive medications for acutely decompensated heart failure: and analysis from a large prospective registry database. J Card Fail. 2003;9:S81.
13. DiDomenico RJ, Park HY, Southworth MR, et al. Guidelines for acute decompensated heart failure treatment. Ann Pharmacother 2004;38:649-660.
14. Francis GS, Siegel RM, Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Intern Med. 1985;103:1-6.
15. Gottlieb SS, Brater DC, Thomas I, et al. BG9719 (CVT-124) an A1 adenosine receptor antagonist protects against the decline in renal function observed with diuretic therapy. Circulation. 2002;105:1348-1353.
16. Cotter G, Metzkor E, Kaluski E, et al. Randomized trial of high-dose isosorbide dinitrate plus low-dose furosemide verus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary edema. Lancet. 1998;351:389-393.
17. Lombardi R, Ferreiro A, Servetto C. Renal function after cardiac surgery: adverse effect of furosemide. Ren Fail. 2003;25:775-786.
18. Bobadilla RV, Oppelt TF, Hirshy TC. Nesiritide treatment of noncardiogenic pulmonary edema. Ann Pharmacother. 2003;37:530-533.
19. Sehra R, Underwood KR. Nesiritide improves urine output in severely ill pediatric patients awaiting heart transplantation without severe hypotension. J Card Fail. 2003;9:S70.
20. Marshall J, Berkenbosch JW, Russo P, et al. Preliminary experience with nesiritide in the pediatric population. J Intensive Care Med. 2004;19:164-170.
21. Simsic JM, Reddy VS, Kanter KR, et al. Use of nesiritide (human b-type natriuretic peptide) in infants following cardiac surgery. Pediatr Cardiol. 2004 Jun 4 epub ahead of print.
22. Smith T, Rosen DA, Russo P, et al. Nesiritide during extracorporeal membrane oxygenation. Paediatr Anaesth (in press).
23. Simsic JM, Scheurer M, Tobias JD, et al. Perioperative effects and safety of nesiritide following cardiac surgery in children. Pediatr Cardiol (submitted).